Corporate News     09-Apr-24
Natco Pharma receives warning letter from USFDA for its Kothur unit
Natco Pharma has received a warning letter dated 08 April 2024 from the United States Food and Drug Administration (USFDA) for its Kothur (Pharma Division) manufacturing facility. The Company does not believe that the warning letter will have an impact on disruption of supplies or existing revenues from this facility. It may cause delay/withholding of pending product approvals from this site.
Previous News
  Volumes spurt at Natco Pharma Ltd counter
 ( Hot Pursuit - 16-Feb-24   14:30 )
  Natco Pharma announces demise of director
 ( Corporate News - 31-Jul-24   11:56 )
  Board of Natco Pharma recommends dividend
 ( Corporate News - 12-Aug-24   15:57 )
  Natco Pharma spurts as Q1 PAT climbs 59% YoY to Rs 668 cr
 ( Hot Pursuit - 12-Aug-24   15:13 )
  Natco Pharma
 ( Results - Analysis 15-Nov-23   14:30 )
  Natco Pharma gets USFDA nod for colorectal cancer drug
 ( Hot Pursuit - 16-Jun-23   10:22 )
  Natco Pharma invests US$2 million in Cellogen Therapeutics
 ( Hot Pursuit - 18-Jan-24   10:49 )
  Natco Pharma Ltd spurts 1.79%
 ( Hot Pursuit - 26-Dec-23   13:05 )
  Natco Pharma gets USFDA approval for carfilzomib vials
 ( Hot Pursuit - 14-Jun-21   11:27 )
  Natco Pharma Ltd rises for third consecutive session
 ( Hot Pursuit - 14-May-24   13:05 )
  Natco Pharma consolidated net profit rises 93.28% in the June 2018 quarter
 ( Results - Announcements 09-Aug-18   16:42 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top